These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7275977)

  • 21. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of murine tumor thymidine kinase activity in vivo following 5-fluorouracil (FUra) treatment by incorporation of FUra into RNA.
    Nord LD; Martin DS
    Biochem Pharmacol; 1991 Nov; 42(12):2369-75. PubMed ID: 1722409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
    Perez DJ; Tattersall MH
    Eur J Cancer Clin Oncol; 1983 Mar; 19(3):371-6. PubMed ID: 6683175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UCN-01 (7-hydroxystaurosporine) enhances 5-fluorouracil cytotoxicity through down-regulation of thymidylate synthetase messenger RNA.
    Abe S; Kubota T; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
    Jpn J Cancer Res; 2000 Nov; 91(11):1192-8. PubMed ID: 11092986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporation of 5-fluorodeoxycytidine and metabolites into nucleic acids of human MCF-7 breast carcinoma cells.
    Kaysen J; Spriggs D; Kufe D
    Cancer Res; 1986 Sep; 46(9):4534-8. PubMed ID: 2425957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of ascorbic acid on incorporation of 6-3H-5-fluorouracil in RNA of tumor tissue of stomach tumor, of unaltered stomach mucosa and of small intestinal mucosa in vitro].
    Shlemkevich MP
    Vopr Med Khim; 1983; 29(1):17-9. PubMed ID: 6188273
    [No Abstract]   [Full Text] [Related]  

  • 27. Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells.
    Grem JL; Nguyen D; Monahan BP; Kao V; Geoffroy FJ
    Biochem Pharmacol; 1999 Aug; 58(3):477-86. PubMed ID: 10424768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incorporation of precursors and inhibitors of nucleic acid synthesis into hepatomas and liver of the rat.
    Lea MA; Khalil FL; Morris HP; Bullock J
    Cancer Res; 1974 Dec; 34(12):3414-20. PubMed ID: 4371961
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of 5-fluorouracil on RNA metabolism in Novikoff hepatoma cells.
    Cory JG; Breland JC; Carter GL
    Cancer Res; 1979 Dec; 39(12):4905-13. PubMed ID: 498116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
    Yoshida M; Hoshi A; Kuretani K
    J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.
    Huber BE; Austin EA; Richards CA; Davis ST; Good SS
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8302-6. PubMed ID: 8058798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance.
    Wang FS; Aschele C; Sobrero A; Chang YM; Bertino JR
    Cancer Res; 1993 Aug; 53(16):3677-80. PubMed ID: 8339275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Biochemical modulation of 5-FU by thymidine and N-phosphoacetyl-L-aspartate: the relation between 5-FU incorporation into RNA and its cytocidal effect].
    Akazawa S; Kumai R; Shimizu K; Ayusawa D; Seno T; Yoshida S
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):990-5. PubMed ID: 3963863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular pharmacology of 5-fluorouracil in a human colon adenocarcinoma cell line selected for thymidine kinase deficiency.
    Radparvar S; Houghton PJ; Germain G; Pennington J; Rahman A; Houghton JA
    Biochem Pharmacol; 1990 Jun; 39(11):1759-65. PubMed ID: 2344373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.
    Noordhuis P; Holwerda U; Van der Wilt CL; Van Groeningen CJ; Smid K; Meijer S; Pinedo HM; Peters GJ
    Ann Oncol; 2004 Jul; 15(7):1025-32. PubMed ID: 15205195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 5-fluorouracil on cytotoxicity and RNA metabolism in human colonic carcinoma cells.
    Greenhalgh DA; Parish JH
    Cancer Chemother Pharmacol; 1989; 25(1):37-44. PubMed ID: 2591000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
    Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
    Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the anti-tumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation.
    Spiegelman S; Sawyer R; Nayak R; Ritzi E; Stolfi R; Martin D
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4966-70. PubMed ID: 6933541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic effects and mechanisms of an alteration in the dose and duration of 5-fluorouracil.
    Patel M; Ardalan K; Hochman I; Tian EM; Ardalan B
    Anticancer Res; 2003; 23(1A):447-52. PubMed ID: 12680247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.